ISB News

Valerie Logan Luncheon Raises $50K for Science Education Programs at ISB

The Second Annual Valerie Logan Luncheon, which took place on Nov. 13, raised just over $50,000 (UPDATE: As of Dec. 18, 2013, the total funds raised has reached more than $60,000) for our education programs at Institute for Systems Biology.

Julia Joo, who spent her summer as an intern at ISB, gave a testimonial during the Second Annual Valerie Logan Luncheon held at Institute for Systems Biology on Nov. 13, 2013. (Photo by Scott Eklund/Red Box Pictures)

Julia Joo, who spent her summer as an intern at ISB, gave a testimonial during the Second Annual Valerie Logan Luncheon held at Institute for Systems Biology on Nov. 13, 2013. (Photo by Scott Eklund/Red Box Pictures)

Guest speaker Julia Joo, who spent her summer as a high school intern here at ISB, shared with us the educational journey that led her to choose science as a career path. “Where my science classes and exposure to local scientists planted the seed of a deep interest in scientific discovery, ISB is truly where the flower of my passion for research bloomed to fruition,” Joo said.

ISB’s president, Dr. Lee Hood, presented the Valerie Logan Leadership in Science Education Award to Dr. Meena Selvakumar, the acting vice president of Strategic Programs at the Pacific Science Center. Among her many achievements, she developed and directs the Portal to the Public Initiative, which focuses on creating opportunities to expose a general audience of all ages to current scientific research and also to train scientists in how to better communicate their work to a lay audience.

Dr. Meena Selvakumar received the Valerie Logan Leadership in Science Education Award from Dr. Lee Hood during the Second Annual Valerie Logan Luncheon, which took place on Nov. 13, 2013, at the Institute for Systems Biology in Seattle. (Photo by Scott Eklund/Red Box Pictures.)

“This has been a true highlight for me,” Dr. Selvakumar said.

Dr. Hood also announced that ISB is creating a strategic plan that enumerates new possibilities for how systems biology can continue to catalyze fundamental changes not only at levels K-12 but also at the undergrad and even graduate levels. “In keeping with all our past successes and this emerging vision – and to honor Valerie Logan – we’re going to rename our program as the Logan Center for Education,” Dr. Hood said.

The education team will share more detailed information about the Logan Center and the education strategic plan in early 2014.

Thank you to all of ISB’s supporters and partners (including corporate sponsors Boeing, Touchstone, Iverson Genetics, Tulalip Tribes, KeyBank and Salal Credit Union) who make it possible for us to continue Valerie’s vision to inspire an ever-growing number of students like Julia to seize opportunities and excel, and to honor leaders in science education.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.